Teva Identifies Teriparatide Importance Amid US Launch Drought

Israeli Firm Sees 15% North America Gx Sales Decline In Q1

 
• By Dean Rudge
Balloons
Teva singled out teriparatide among its 2022 opportunities • Source: Shutterstock

More from Earnings

More from Business